Clinical Trials with Antithrombotic and Thrombolytic Agents

Thromb Haemost 1973; 29(01): 003-010
DOI: 10.1055/s-0038-1647741

Original Article

Schattauer GmbH

Principles and Pitfalls^[*]

Sol Sherry

¹Department of Medicine and the Specialized Center for Thrombosis Research, Temple University School of Medicine Philadelphia, Pennsylvania

References
1 Bass N. Personal communication.
2 Dioguardi N, Lotto A, Levi G. F. 1971 Controlled trial of streptokinase and heparin in acute myocardial infarction. Lancet. 02. 891.
3 European Working Party. 1971; Streptokinase in acute myocardial infarction. A controlled multicentre trial. British Medical Journal 02: 325.
4 Hale G. S. 1970 Streptokinase in acute myocardial infarction. Rationale and preliminary results of a combined therapeutic trial. Australian Annals of Medicine. 19. suppl. 1, 63 and personal communication.
5 Heikinheimo R, Ahrenberg P, Honkapohja H. 1971; Fibrinolytic treatment in acute myocardial infarction. Acta Medica Scandinavica 189: 7.
6 Schmutzler R, Fritze E, Gebauer D. 1970 Fibrinolytic therapy of acute myocardial infarction. XIII International Congress of Hematology. Munich August. 2-8. 1970.
7 Schmutzler R, Hecknee F, Kortge P. 1966; Thrombolytic Therapy of recent myocardial infarction. I. Introduction, plan of trial, general clinical results. German Medical Monthly 11: 308.